Liver Diseases  >>  mycophenolate mofetil  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mycophenolate mofetil / Generic mfg.
REVERT, NCT00582738: Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Terminated
2
43
RoW
CsA-TAC (standard Treatment), Everolimus
Novartis Pharmaceuticals
Recurrent Hepatitis C
01/10
01/10

Download Options